Health Care: Drugs

Emergent BioSolutions Inc (EBS: NYSE)

$34.65 0.71 | 2.09%
06/23/17 - 04:07 PM ET
Company Profile
Price and Volume
Recent Price 33.94
52 Week High 36.64
52 Week Low 24.47
Avg. Daily Vol. (Mil) 0.32
Beta (3 year) 1.59
Share Related Items
Mkt Cap (Mil) 1,390.67
Shares Out (Mil) 40.97
Float (Mil) 30.80
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.00
Current Ratio 7.20
LT Debt/ Equity 0.41
Total Debt / Equity 0.41
Valuation Ratios
Price Earnings 28.80
Price/Sales 2.71
Price/Book 2.28
Price/Cash Flow 14.20
Per Share Data
Earnings 1.18
Sales 12.52
Book Value 14.90
Cash Flow 2.39
Business Summary
Emergent BioSolutions Inc is a biotechnology company operating in two divisions: biodefense and biosciences. The company focuses on countermeasures that address public health threats around hematology and oncology therapeutics.
General Information
400 Professional Drive
Suite 400
Gaithersburg, MD 20879
www.emergentbiosolutions.com
Industry : Drugs
Sector: Health Care
Employees: 1098
CEO: Daniel J. Abdun-Nabi
Short Interest
Current Month (Mil) 3.03
Previous Month (Mil) 3.14
Short Interest Ratio (Days) 8.60
Management Effectiveness
Return on Equity 9.50
Return on Assets 6.10
Return on Investments 6.80
Profitability
Gross Margin 76.60
EBIT Margin 17.40
Profit Margin 11.40

Portfolios with EBS

Latest EBS Headlines from TheStreet

More Financial News for EBS

Press Releases for EBS

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter